Dep Cabazitaxel effective against stage III cholangiocarcinoma, page-4

@peony-rose let's hope for your sake it doesn't progress to cholangiocarcinoma, however if it does I would suggest you research all possibilities for treatment. Another ASX biotech has had Complete Responses in similar areas with their treatments that I believe have little side effects..... best to keep your options open and good luck with it all


In my honest opinion there are newer and better treatments out there (akin to what JF stated in her 2022 AGM address as to why Starpharma were struggling with recruitment numbers for our phase 2 trials) and this is in my opinion is why Starpharma are struggling to secure a DEP license deal after years of discussions / negotiations with 'several' potential partners